AI assistant
ANTEOTECH LTD — Capital/Financing Update 2011
Aug 30, 2011
64304_rns_2011-08-30_66794502-3492-461c-90da-5f0e239c1238.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [198 x 108] intentionally omitted <==
31[st] August 2011 Company’s Announcement Office ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000
ASX ANNOUNCEMENT / MEDIA RELEASE Proposed Issue of Director Options
As outlined in the Company’s 2011 Annual Report lodged with the Australian Securities Exchange (“ASX”) on 30[th] August 3011, the Board has resolved, subject to shareholder approval to issue the following options to certain Directors.
Pursuant to ASX Listing Rule 3.10.3, the Company provides the following information:
| Class of Securities to be Issued: | Options to purchase fully paid ordinary shares in ADO |
|---|---|
| Number to be Issued: | 9,600,000 |
| Principal terms of the securities to be | Exercise Price of $0.12; |
| issued: | Expiry 4 years from date of issue. |
| Issue Price: | Nil |
| Purpose of the Issue: | The options to represent the Director’s Long Term |
| Incentive component of their respective remuneration | |
| packages. | |
| Shareholder Approval: | The Company will seek approval of its shareholders for |
| the issue of the options at the upcoming Annual General | |
| Meeting of the Company. | |
| Parties to be issued to: | Mr Mark Bouris 5,000,000 |
| Ms Sandra Andersen 3,000,000 | |
| Mr Richard Martin 1,600,000 |
For further information please contact:
Dr Geoff Cumming, CEO, Anteo Diagnostics Limited Tel: +612 8823 3110
Anteo Diagnostics Limited ABN 75 070 028 625
Unit 4, 26 Brandl Street, Eight Mile Plains Qld 4113 Phone 07 3219 0085 Fax 07 3219 0553 Email [email protected] Web www.anteodx.com